P

Palisade Bio
D

PALI

0.61620
USD
-0.05
(-6.86%)
مغلق
حجم التداول
2,880
الربح لكل سهم
-2
العائد الربحي
-
P/E
-0
حجم السوق
3,078,317
الأخبار المقالات

العنوان: Palisade Bio

القطاع: Healthcare
الصناعة: Biotechnology
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.